Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0034186 (
pyelonephritis
)
6,144
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
DCs and macrophages both express the chemokine receptor
CX3CR1
. Here we demonstrate that its ligand, CX3CL1, is highly expressed in the murine kidney and intestine.
CX3CR1
deficiency markedly reduced DC numbers in the healthy and inflamed kidney cortex, and to a lesser degree in the kidney medulla and intestine, but not in other organs.
CX3CR1
also promoted influx of DC precursors in crescentic glomerulonephritis, a DC-dependent aggressive type of nephritis. Disease severity was strongly attenuated in
CX3CR1
-deficient mice. Primarily
CX3CR1
-dependent DCs in the kidney cortex processed antigen for the intrarenal stimulation of T helper cells, a function important for glomerulonephritis progression. In contrast, medullary DCs played a specialized role in inducing innate immunity against bacterial
pyelonephritis
by recruiting neutrophils through rapid chemokine production.
CX3CR1
deficiency had little effect on the immune defense against
pyelonephritis
, as medullary DCs were less
CX3CR1
dependent than cortical DCs and because recruited neutrophils produced chemokines to compensate for the DC paucity. These findings demonstrate that cortical and medullary DCs play specialized roles in their respective kidney compartments. We identify
CX3CR1
as a potential therapeutic target in glomerulonephritis that may involve fewer adverse side effects, such as impaired anti-infectious defense or compromised DC functions in other organs.
...
PMID:Exclusive CX3CR1 dependence of kidney DCs impacts glomerulonephritis progression. 2399 31